Holocene Advisors’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-24,174
Closed -$1.71M 927
2026
Q1
$1.71M Buy
+24,174
New +$1.81M ﹤0.01% 595
2025
Q1
Sell
-267,877
Closed -$21.9M 840
2024
Q4
$21.9M Buy
267,877
+215,075
+407% +$17.9M 0.07% 250
2024
Q3
$4.36M Buy
+52,802
New +$3.94M 0.02% 396
2024
Q1
Sell
-43,323
Closed -$2.86M 809
2023
Q4
$2.86M Buy
+43,323
New +$2.71M 0.01% 462
2023
Q1
Sell
-101,768
Closed -$7.36M 821
2022
Q4
$7.36M Buy
+101,768
New +$7.29M 0.04% 243
2019
Q1
Sell
-25,921
Closed -$1.06M 738
2018
Q4
$1.06M Buy
+25,921
New +$1.11M 0.02% 253
2018
Q3
Sell
-6,360
Closed -$277K 775
2018
Q2
$277K Sell
6,360
-4,024
-39% -$188K 0.01% 501
2018
Q1
$477K Buy
+10,384
New +$504K 0.01% 283

Other funds holding MET

Holocene Advisors's MET Position: Q2 2026 in Review

Holocene Advisors sold out of MetLife (MET) in Q2 2026, closing a stake of 24,174 shares — an estimated $1.71M sold.

Holocene Advisors first reported a position in MET in Q1 2018 and held it in 8 quarters. The position peaked at $21.9M in Q4 2024. 1,442 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Holocene Advisors reported no remaining MetLife position as of Q2 2026 after selling out during the quarter.
  • Holocene Advisors sold 24,174 MetLife shares in Q2 2026, an estimated $1.71M.
  • Holocene Advisors first reported a position in MetLife in Q1 2018 and held it in 8 quarters.
  • Holocene Advisors's MetLife position peaked at $21.9M in Q4 2024.
  • 1,442 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Holocene Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.